Skip to main navigation Skip to search Skip to main content

Reliability and Construct Validity of the Physician's Global Assessment of Lung Disease in Systemic Juvenile Idiopathic Arthritis–Associated Lung Disease

  • for the PGALD Validation Consortium Investigators

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: The physician global assessment of lung disease (PGALD) is a recently proposed disease activity measure for patients with systemic juvenile idiopathic arthritis–associated lung disease (SJIA-LD). This study evaluates the reliability and construct validity of the PGALD. Methods: Fifty-seven pediatric rheumatologists and pulmonologists with experience caring for children with SJIA-LD were invited to rate 20 clinical vignettes using the PGALD, a 10-point Likert scale (0 = inactive SJIA-LD; 10 = highly active SJIA-LD). Raters were also asked to rate a subset of eight repeat vignettes. Interrater and intrarater reliability were assessed using intraclass correlation coefficients (ICCs), whereas SJIA-LD features influencing PGALD ratings were assessed using univariate analysis. Results: The ICC for all raters was 0.68 (95% confidence interval [CI] 0.54–0.82), indicating moderate to good interrater reliability. The retest ICC was 0.86 (95% CI 0.82–0.89), indicating good intrarater reliability. Factors associated with higher mean PGALD scores included the presence of crackles on auscultation (5.7 vs 2.9; P = 0.001), hypoxemia on pulse oximeter (5.6 vs 3.2; P = 0.01), current oxygen requirement (6.3 vs 3.5; P = 0.04), suggestive diagnostic imaging features (P ≤ 0.01), and three or more prescribed medications for SJIA-LD (P ≤ 0.01). Pulmonary function measures demonstrated significant negative correlations with PGALD scores: forced vital capacity (r = −0.71; P = 0.01), total lung capacity (r = −0.92; P = 0.01), and lung diffusion capacity (r = −0.97; P = 0.0002). Only C-reactive protein was weakly to moderately correlated with PGALD scores (r = 0.39; P = 0.09), whereas other laboratory markers (ferritin, interleukin 18, CXCL9, and sIL-2R) were not significantly correlated. Conclusions: The PGALD is a novel measure of SJIA-LD activity. Its initial validation suggests acceptable construct validity and reliability. Additional studies are needed to assess its responsiveness to change over time.

Original languageEnglish (US)
Article numbere90006
JournalACR Open Rheumatology
Volume8
Issue number3
DOIs
StatePublished - Mar 2026

Bibliographical note

Publisher Copyright:
© 2026 The Author(s). ACR Open Rheumatology published by Wiley Periodicals LLC on behalf of American College of Rheumatology.

PubMed: MeSH publication types

  • Journal Article

Fingerprint

Dive into the research topics of 'Reliability and Construct Validity of the Physician's Global Assessment of Lung Disease in Systemic Juvenile Idiopathic Arthritis–Associated Lung Disease'. Together they form a unique fingerprint.

Cite this